MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
159
Participants
Timeline
Start Date
June 30, 2002
Primary Completion Date
December 31, 2006
Study Completion Date
April 30, 2007
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG
gemcitabine prolonged continuous infusion
DRUG
cisplatin
DRUG
vinorelbine
All Listed Sponsors
lead
National Cancer Institute, Naples
OTHER
NCT00401492 - MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter